Form 4: Goldman Sachs CFO Denis Coleman Sells Over 9,500 Shares

Goldman Sachs Chief Financial Officer Denis P. Coleman reported the sale of 9,539 shares of common stock on July 25, 2025, through multiple transactions at prices ranging from $723.83 to $727.79 per share.

Summary

• Denis P. Coleman, Chief Financial Officer of Goldman Sachs Group Inc. (GS), reported the sale of 9,539 shares of common stock.
• The sales occurred on July 25, 2025, across four separate transactions.
• The weighted average sale prices ranged from $723.83 to $727.79 per share.
• Specifically, 5,455 shares were sold at $723.83, 2,076 shares at $724.57, 1,681 shares at $725.60, and 327 shares at $727.79.
• Following these transactions, Mr. Coleman directly beneficially owns 18,594 shares.
• An additional 4,118 shares are indirectly held through trusts for immediate family members, with Mr. Coleman disclaiming beneficial ownership of these shares.
• The transactions were conducted pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 5

Explanation: The sale of shares by a CFO, while reducing direct ownership, was conducted under a Rule 10b5-1 plan, which suggests a pre-planned, non-discretionary transaction rather than a reaction to negative company news. This makes the event largely neutral in terms of immediate sentiment.

Positives

• The transactions were executed under a Rule 10b5-1(c) plan, indicating a pre-scheduled sale rather than a reaction to immediate market conditions or insider information.

Negatives

• An insider sale, particularly by a Chief Financial Officer, can sometimes be perceived negatively by the market as it reduces management's direct equity stake in the company.

Future Outlook

This filing does not contain any forward-looking statements or guidance.

Industry Context

Insider transactions, such as the sale reported by Goldman Sachs' CFO, are common occurrences in the financial industry. They are often part of executives' compensation plans, personal financial management, or pre-arranged trading plans (like Rule 10b5-1 plans) designed to avoid accusations of trading on material non-public information. The sale itself does not inherently indicate a change in the company's strategic direction or financial health, especially when conducted under a 10b5-1 plan.

Comparison to Industry Standards

• This filing is a standard Form 4 reporting an insider transaction. There are no specific company or project results to compare against industry benchmarks.
• Insider sales are a common practice across all publicly traded companies, including major financial institutions like JPMorgan Chase, Morgan Stanley, or Bank of America, where executives periodically sell shares for liquidity or diversification, often through pre-scheduled plans.
• The volume and frequency of such sales are typically monitored by investors, but a single transaction, especially under a 10b5-1 plan, is generally considered routine.

Related Party Transactions

• 4,118 shares are indirectly held through trusts, the sole beneficiaries of which are immediate family members of the Reporting Person. The Reporting Person disclaims beneficial ownership of these shares.

Stakeholder Impact

• Shareholders: The sale slightly reduces the direct equity alignment of a key executive, which could be viewed neutrally or slightly negatively, though the 10b5-1 plan mitigates concerns.
• Employees, Customers, Suppliers, Creditors: No direct impact on these stakeholders is indicated by this filing.

Key Dates

Recommendation

This Form 4 filing reports a routine insider share sale by the CFO under a pre-arranged 10b5-1 plan. Such transactions are common and generally do not signal a fundamental change in the company's prospects or warrant a change in investment thesis. While a reduction in insider ownership can be a minor negative, the pre-planned nature of the sale mitigates concerns about its implications. Therefore, based solely on this filing, a "hold" recommendation is appropriate as it provides no new material information to alter an existing investment stance.

Keywords

Goldman Sachs, GS, Insider Trading, Form 4, Denis Coleman, CFO, Share Sale, Equity Transaction, Rule 10b5-1